Richard R. Neubig

Career Trajectory

Research Cluster Map

Direct collaborators. Node size = influence, colour = community, dashed = past collaboration.

• Abstract 975: Deep learning-based screening and design of novel therapeutics that reverse cancer-associated transcriptional phenotypes

  Cancer Research · 2026-04-03

• Deep-learning-based de novo discovery and design of therapeutics that reverse disease-associated transcriptional phenotypes

  Cell · 2026-03-17 · 1 citations

• Understanding how treatment responses alter the myeloid compartment in BRAF-mutant melanoma 2604

  The Journal of Immunology · 2025-11-01

• Class A Orphans in GtoPdb v.2025.3

  IUPHAR/BPS Guide to Pharmacology CITE · 2025-09-10

• Optimization of a direct Serum Response Factor Inhibitor Peptide

  Spartan Medical Research Journal · 2025-09-04

• Pseudogenization of a resistance-nodulation-division (RND) efflux pump subunit underlies drug and cell envelope stress sensitivity in Brucella ovis

  Spartan Medical Research Journal · 2025-08-21

• Pirin does not bind to p65 or regulate NFκB-dependent gene expression but does modulate cellular quercetin levels

  Molecular Pharmacology · 2025-08-08

• Reversion of a RND transporter pseudogene reveals latent stress resistance potential in Brucella ovis

  PLoS Genetics · 2025-07-21 · 1 citations

• Class A Orphans in GtoPdb v.2025.2

  IUPHAR/BPS Guide to Pharmacology CITE · 2025-06-18 · 1 citations

• Reversion of a RND transporter pseudogene uncovers latent stress resistance in <i>Brucella ovis</i>Preprint

  bioRxiv (Cold Spring Harbor Laboratory) · 2025-05-10

• Class A Orphans in GtoPdb v.2025.1

  IUPHAR/BPS Guide to Pharmacology CITE · 2025-04-01

• Mechanistic insights into Rho/MRTF inhibition-induced apoptotic events and prevention of drug resistance in melanoma: implications for the involvement of pirin

  Frontiers in Pharmacology · 2025-01-23 · 4 citations

• Pirin does not bind to p65 or regulate NFκB-dependent gene expression but does modulate cellular quercetin levelsPreprint

  bioRxiv (Cold Spring Harbor Laboratory) · 2024-12-04

• Mechanistic insights into Rho/MRTF inhibition-induced apoptotic events and prevention of drug resistance in melanoma: Implications for the involvement of pirinPreprint

  bioRxiv (Cold Spring Harbor Laboratory) · 2024-09-24

• DEVELOPMENT OF AN SRF INHIBITOR PEPTIDE FOR THE TREATMENT OF CARDIAC FIBROSIS

  Spartan Medical Research Journal · 2024-08-30